Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

Nature Medicine

Volumn 17, Issue 12, 2011, Pages 1657-1662

  Paşca, Sergiu P ^a   Portmann, Thomas ^a   Voineagu, Irina ^b   Yazawa, Masayuki ^a   Shcheglovitov, Aleksandr ^a   Paşca, Anca M ^a   Cord, Branden ^a   Palmer, Theo D ^a   Chikahisa, Sachiko ^a,c   Nishino, Seiji ^a   Bernstein, Jonathan A ^a   Hallmayer, Joachim ^a   Geschwind, Daniel H ^b   Dolmetsch, Ricardo E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL L TYPE; DOPAMINE; NORADRENALIN; ROSCOVITINE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; AUTISM; BRAIN CELL; CALCIUM SIGNALING; CELL DIFFERENTIATION; CORPUS CALLOSUM; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL; TIMOTHY SYNDROME; UPREGULATION;

AUTISTIC DISORDER; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL LINE; DOPAMINE; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LONG QT SYNDROME; MICROARRAY ANALYSIS; NEURONS; NOREPINEPHRINE; PHENOTYPE; PURINES; SYNDACTYLY; TYROSINE 3-MONOOXYGENASE;

PHLEUM PRATENSE;

EID: 84856088804     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2576     Document Type: Article

References (33)

1. Splawski I. et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31 (2004). (Pubitemid 39349317)
2. Yarotskyy V. et al. Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation. J. Biol. Chem. 285, 43-53 (2010).
3. Yarotskyy V. & Elmslie K.S. Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels. Br. J. Pharmacol. 152, 386-395 (2007). (Pubitemid 47511263)
4. Yarotskyy V., Gao G., Peterson B.Z. & Elmslie K.S. The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: Multiple altered gating mechanisms and pharmacological restoration of inactivation. J. Physiol. (Lond.) 587, 551-565 (2009).
5. Wang K. et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459, 528-533 (2009).
6. Moskvina V. et al. Gene-wide analyses of genome-wide association data sets: Evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 14, 252-260 (2009).
7. Nyegaard M. et al. CACNA1C (rs1006737) is associated with schizophrenia. Mol. Psychiatry 15, 119-121 (2010).
8. Dolmetsch R.E., Pajvani U., Fife K., Spotts J.M. & Greenberg M.E. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294, 333-339 (2001). (Pubitemid 32963394)
9. Barrett C.F. & Tsien R.W. The Timothy syndrome mutation differentially affects voltage-and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc. Natl. Acad. Sci. USA 105, 2157-2162 (2008). (Pubitemid 351439481)
10. Takahashi K. & Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
11. Yu J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
12. Yazawa M. et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234 (2011).
13. Zhang S.C., Wernig M., Duncan I.D., Brustle O. & Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19, 1129-1133 (2001). (Pubitemid 33115698)
14. Pankratz M.T. et al. Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25, 1511-1520 (2007). (Pubitemid 47106020)
15. Li X.J. et al. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 136, 4055-4063 (2009).
16. Warren L., Bryder D., Weissman I.L. & Quake S.R. Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc. Natl. Acad. Sci. USA 103, 17807-17812 (2006). (Pubitemid 44852241)
17. Flatz L. et al. Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines. Proc. Natl. Acad. Sci. USA 108, 5724-5729 (2011).
18. Garbelli R. et al. Layer-specific genes reveal a rudimentary laminar pattern in human nodular heterotopia. Neurology 73, 746-753 (2009).
19. Saito T. et al. Neocortical layer formation of human developing brains and lissencephalies: Consideration of layer-specific marker expression. Cereb. Cortex 21, 588-596 (2010).
20. Alcamo E.A. et al. Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57, 364-377 (2008). (Pubitemid 351179160)
21. Britanova O. et al. Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 57, 378-392 (2008). (Pubitemid 351179166)
22. Leone D.P., Srinivasan K., Chen B., Alcamo E. & McConnell S.K. The determination of projection neuron identity in the developing cerebral cortex. Curr. Opin. Neurobiol. 18, 28-35 (2008).
23. Pinto D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368-372 (2010).
24. Garbett K. et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 30, 303-311 (2008).
25. Ip B.K., Bayatti N., Howard N.J., Lindsay S. & Clowry G.J. The corticofugal neuron-associated genes ROBO1, SRGAP1 and CTIP2 exhibit an anterior to posterior gradient of expression in early fetal human neocortex development. Cereb. Cortex 21, 1395-1407 (2011).
26. Romano G., Suon S., Jin H., Donaldson A.E. & Iacovitti L. Characterization of five evolutionary conserved regions of the human tyrosine hydroxylase (TH) promoter: Implications for the engineering of a human TH minimal promoter assembled in a self-inactivating lentiviral vector system. J. Cell. Physiol. 204, 666-677 (2005). (Pubitemid 40934663)
27. Raghanti M.A. et al. Species-specific distributions of tyrosine hydroxylase-immunoreactive neurons in the prefrontal cortex of anthropoid primates. Neuroscience 158, 1551-1559 (2009).
28. Dulcis D. & Spitzer N.C. Illumination controls differentiation of dopamine neurons regulating behaviour. Nature 456, 195-201 (2008).
29. Barttfeld P. et al. A big-world network in ASD: Dynamical connectivity analysis reflects a deficit in long-range connections and an excess of short-range connections. Neuropsychologia 49, 254-263 (2011).
30. Geschwind D.H. & Levitt P. Autism spectrum disorders: Developmental disconnection syndromes. Curr. Opin. Neurobiol. 17, 103-111 (2007). (Pubitemid 46237744)
31. Casanova M.F. et al. Reduced gyral window and corpus callosum size in autism: Possible macroscopic correlates of a minicolumnopathy. J. Autism Dev. Disord. 39, 751-764 (2009).
32. D'Souza A., Onem E., Patel P., La Gamma E.F. & Nankova B.B. Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res. 1247, 1-10 (2009).
33. Toru M., Nishikawa T., Mataga N. & Takashima M. Dopamine metabolism increases in post-mortem schizophrenic basal ganglia. J. Neural Transm. 54, 181-191 (1982). (Pubitemid 12022953)